Lessons From the ARCHER Trial - Quiz - MDSpire

Lessons From the ARCHER Trial

Margaret A. Chang, MD, MS, discusses how findings from the phase 2 ARCHER trial informed the design of the ongoing phase 3 ARCHER II study of vonaprument, which is expected to read out later this year.

  • By

  • Margaret Chang, MD

  • July 15, 2026

  • 2 min

Share

Original Source(s)

Lessons From the ARCHER Trial

  • by Margaret Chang, MD

  • July 15, 2026

Related Content

Glaucoma in the UK

Largest-ever UK glaucoma patient survey launches to shape future eye care services in the country

  • July 16, 2026

  • 3 min
A First Look at Phase 2 ArMaDa Data

Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.

Alkeus Launches Phase 3 Stargardt Trial

At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.